Despite recent struggles, the firm remains optimistic about its position as the first and only direct-from-blood sepsis test system.
University of Pittsburgh researchers showed that real-time pathogen whole-genome sequencing can help curb healthcare-associated infections within a hospital.
Biotia Raises $8M in Series A Financing
The New York-based startup said the funding will be used to expand its technical capabilities, regulatory compliance, and marketing reach.
Illumina Acquires IDbyDNA
The firms have had an alliance for the past two years and market a respiratory pathogen panel.
BugSeq Bioinformatics Nabs BARDA Grant to Develop NGS-Based Respiratory Test
BugSeq will optimize a test for commercial clinical use by lowering the turnaround time, reducing interference from host RNA, and analytically validating the platform.